The $45 billion musculoskeletal market is getting ever more consolidated and the latest mega-deal will alter the landscape dramatically. With Zimmer‘s (NYSE:ZMH) impending $13.35 billion merger with hometown rival Biomet, we’ll be able to count orthopedics industry giants on one hand.
Prior to the deal, Zimmer sat at 3rd place a respectable 10.3% market share and Biomet took 5th place with about 7% of the market. When they join forces, pending regulatory approvals, the duo will form the 2nd largest player in the industry.
Before the Merger*
Zimmer sat in 3rd place with 10.3% market share and Biomet took 5th with 7% share.
*Figures are based on 2013 revenue estimates and market share in the $45 billion musculoskeletal industry
- J&J’s DePuy Synthes: $9,002 million
- Stryker: $5,800 million
- Zimmer: $4,620 million
- Medtronic: $3,200 million
- Biomet: $3,140 million
- Smith & Nephew: $3,000 million
- NuVasive: $685 million
- Tornier NV: $311 million
- Wright Medical: $242.3 million
- Other: $8,379.7 million
After the Merger
Zimmer and Biomet combine to become the 2nd largest player on he field, taking more than 17% market share.